Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study

OBJECTIVE: Treatment of severe ulcerative colitis (UC) is challenging. Although the efficacy of tacrolimus (TAC) and infliximab (IFX) have been evaluated in patients with severe UC, the safety and efficacy levels of sequential therapies (TAC→IFX/IFX→TAC) in these patients remain unclear. The aim of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open Gastroenterol
Egile Nagusiak: Minami, Naoki, Yoshino, Takuya, Matsuura, Minoru, Koshikawa, Yorimitsu, Yamada, Satoshi, Toyonaga, Takahiko, Madian, Ali, Honzawa, Yusuke, Nakase, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2015
Gaiak:
Inflammatory Bowel Disease
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599165/
https://ncbi.nlm.nih.gov/pubmed/26462273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000021
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak